NCT00115609View on ClinicalTrials.gov

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
HIV InfectionsTuberculosis
Interventions
DRUG

efavirenz

800mg for patients treated by rifampicine 600mg for other patients

DRUG

tenofovir DF

300mg once a day

DRUG

emtricitabine

one pill of 200mg once a day

Trial Locations (1)

75015

Service des maladies Infectieuses et tropicales Hopital Necker-Enfants Malades, Paris

All Listed Sponsors
lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00115609 - Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) | Biotech Hunter | Biotech Hunter